Nectar Lifesciences Limited (NSE:NECLIFE)
India
· Delayed Price · Currency is INR 18.35
+0.42 (2.34%)
Jul 16, 2025, 2:30 PM IST
Nectar Lifesciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 192.22 | 198.06 | 175.8 | 178.08 | 255.39 | Upgrade
|
Short-Term Investments | 5.3 | - | - | - | 4.57 | Upgrade
|
Trading Asset Securities | - | 4.95 | 3.14 | 4.6 | - | Upgrade
|
Cash & Short-Term Investments | 197.51 | 203.01 | 178.94 | 182.68 | 259.96 | Upgrade
|
Cash Growth | -2.71% | 13.45% | -2.05% | -29.73% | 21.14% | Upgrade
|
Accounts Receivable | 3,455 | 3,792 | 2,796 | 4,470 | 3,748 | Upgrade
|
Other Receivables | 75.12 | 423.11 | 637.78 | 670.53 | 463.64 | Upgrade
|
Receivables | 3,539 | 4,224 | 3,438 | 5,144 | 4,216 | Upgrade
|
Inventory | 6,902 | 7,765 | 7,315 | 7,213 | 6,553 | Upgrade
|
Other Current Assets | 1,738 | 645.76 | 1,380 | 1,009 | 1,359 | Upgrade
|
Total Current Assets | 12,376 | 12,838 | 12,312 | 13,548 | 12,388 | Upgrade
|
Property, Plant & Equipment | 6,333 | 6,561 | 6,904 | 7,652 | 8,322 | Upgrade
|
Long-Term Investments | 2.35 | 2.35 | 2.35 | 2.35 | 2.35 | Upgrade
|
Other Intangible Assets | 565.04 | 523.93 | 493.29 | 430.21 | 383.64 | Upgrade
|
Long-Term Accounts Receivable | 84.87 | 81.54 | 73.46 | 78.28 | 102.89 | Upgrade
|
Long-Term Deferred Tax Assets | 550.41 | 74.78 | 205.69 | 28 | 122.79 | Upgrade
|
Other Long-Term Assets | 560.37 | 1,829 | 1,901 | 2,169 | 2,560 | Upgrade
|
Total Assets | 20,472 | 21,911 | 21,892 | 23,908 | 23,881 | Upgrade
|
Accounts Payable | 4,381 | 4,197 | 3,188 | 3,767 | 3,422 | Upgrade
|
Accrued Expenses | 29.22 | 153.5 | 104.43 | 510.46 | 144.13 | Upgrade
|
Short-Term Debt | - | 4,122 | 4,589 | 5,028 | 7,120 | Upgrade
|
Current Portion of Long-Term Debt | 5,219 | 830.1 | 684.45 | 660.81 | 631.67 | Upgrade
|
Other Current Liabilities | 586.08 | 425.78 | 343.74 | 72.85 | 556.55 | Upgrade
|
Total Current Liabilities | 10,215 | 9,728 | 8,909 | 10,038 | 11,874 | Upgrade
|
Long-Term Debt | 601.27 | 1,403 | 2,265 | 2,911 | 1,282 | Upgrade
|
Long-Term Unearned Revenue | 7.21 | 7.46 | 7.71 | 7.96 | 8.21 | Upgrade
|
Other Long-Term Liabilities | - | -0.01 | 0.01 | 8.3 | 18.95 | Upgrade
|
Total Liabilities | 10,911 | 11,218 | 11,246 | 13,029 | 13,261 | Upgrade
|
Common Stock | 224.26 | 224.26 | 224.26 | 224.26 | 224.26 | Upgrade
|
Additional Paid-In Capital | - | 3,288 | 3,288 | 3,288 | 3,288 | Upgrade
|
Retained Earnings | - | 7,180 | 7,134 | 7,367 | 7,108 | Upgrade
|
Comprehensive Income & Other | 9,337 | - | - | - | - | Upgrade
|
Shareholders' Equity | 9,561 | 10,692 | 10,646 | 10,879 | 10,620 | Upgrade
|
Total Liabilities & Equity | 20,472 | 21,911 | 21,892 | 23,908 | 23,881 | Upgrade
|
Total Debt | 5,820 | 6,355 | 7,538 | 8,599 | 9,034 | Upgrade
|
Net Cash (Debt) | -5,623 | -6,152 | -7,359 | -8,417 | -8,774 | Upgrade
|
Net Cash Per Share | -25.08 | -27.43 | -32.82 | -37.53 | -39.12 | Upgrade
|
Filing Date Shares Outstanding | 224.29 | 224.26 | 224.26 | 224.26 | 224.26 | Upgrade
|
Total Common Shares Outstanding | 224.29 | 224.26 | 224.26 | 224.26 | 224.26 | Upgrade
|
Working Capital | 2,160 | 3,110 | 3,403 | 3,510 | 514.36 | Upgrade
|
Book Value Per Share | 42.63 | 47.68 | 47.47 | 48.51 | 47.36 | Upgrade
|
Tangible Book Value | 8,996 | 10,169 | 10,153 | 10,449 | 10,237 | Upgrade
|
Tangible Book Value Per Share | 40.11 | 45.34 | 45.27 | 46.59 | 45.65 | Upgrade
|
Land | - | 192.35 | 192.35 | 516.05 | 806.42 | Upgrade
|
Buildings | - | 1,803 | 1,760 | 1,773 | 1,750 | Upgrade
|
Machinery | - | 10,186 | 10,011 | 9,936 | 9,753 | Upgrade
|
Construction In Progress | - | 657.5 | 777.83 | 850.98 | 986.29 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.